Nations with emerging deceased-donor liver transplantation programs, such as India, face problems associated with poor donor maintenance. Cold ischemic time (CIT) is typically maintained short by matching donor organ recovery and recipient hepatectomy to achieve maximum favorable outcome. We analyzed different extended criteria donor factors including donor acidosis, which may act as a surrogate marker of poor donor maintenance, to quantify the risk of primary nonfunction (PNF) or initial poor function (IPF).
Methods:
A single-center retrospective outcome analysis of prospectively collected data of patients undergoing deceased-donor liver transplantation over 2 years to determine the impact of different extended criteria donor factors on IPF and PNF.
Results:
From March 2013 to February 2015, a total of 84 patients underwent deceased-donor liver transplantation. None developed PNF. Thirteen (15.5%) patients developed IPF. Graft macrosteatosis and donor acidosis were only related to IPF (P = .002 and P = .032, respectively). Cold ischemic time was maintained short (81 cases ≤8 hours, maximum 11 hours) in all cases.
Conclusion:
Poor donor maintenance as evidenced by donor acidosis and graft macrosteatosis had significant impact in developing IPF when CIT is kept short. Similar study with larger sample size is required to establish extended criteria cutoff values.
NagralSAmalopravanathanJ. Deceased organ donation in India: where do we go from here?Indian J Med Ethics. 2014;11(3):162–166.
2.
AttiaMSilvaMAMirzaDF. The marginal liver donor—an update. Transpl Int. 2008;21(8):713–724. doi:10.1111/j.1432-2277.2008.00696.x.
3.
StarzlTEMillerCBroznickBMakowkaL. An improved technique for multiple organ harvesting. Surg Gynecol Obstet. 1987;165(4):343–348.
4.
NanashimaAPillayPVerranDJPainterDNakasujiMCrawfordM. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc. 2002;34(4):1231–1235.
5.
HodgsonRChristophiC. What determines ageing of the transplanted liver?HPB (Oxford). 2015;17(3):222–225. doi:10.1111/hpb.12339.
6.
NickkholghAWeitzJEnckeJ. Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant. 2007;22(suppl 8):viii29–viii36.
7.
Jiménez-RomeroCCaso MaestroOCambra MoleroF. Using old liver grafts for liver transplantation: where are the limits?World J Gastroenterol. 2014;20(31):10691–10702. doi:10.3748/wjg.v20.i31.10691.
8.
MalhotraNBeatonMD. Management of non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015;7(30):2962–2967. doi:10.4254/wjh.v7.i30.2962.
9.
TakedaYAriiSKaidoT. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation. 1999;67(6):820–828.
10.
FukumoriTOhkohchiNTsukamotoSSatomiS. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation. 1999;67(2):195–200.
11.
GoceriEShahZKLaymanRJiangXGurcanMN. Quantification of liver fat: a comprehensive review. Comput Biol Med. 2016;71:174–189. doi:10.1016/j.compbiomed.2016.02.013.
12.
DerooseJPKazemierGZondervanPIjzermansJNMetselaarHJAlwaynIP. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford). 2011;13(6):417–425. doi:10.1111/j.1477-2574.2011.00310.x.
13.
ZibariGBLipkaJZizziHAbreoKDJacobbiLMcDonaldJC. The use of contaminated donor organs in transplantation. Clin Transplant. 2000;14(4 pt 2):397–400.
14.
CeruttiEStrattaCRomagnoliR. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl. 2006;12(8):1253–1259.
15.
JaeschkeH.Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290(6):G1083–G1088.
16.
WeigandKBrostSSteinebrunnerNBüchlerMSchemmerPMüllerM. Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg. 2012;2012:176723. doi:10.1155/2012/176723.
17.
PiratvisuthTTredgerJMHayllarKAWilliamsR. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg. 1995;1(5):296–301.
18.
de VeraMELopez-SolisRDvorchikI. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773–781. doi:10.1111/j.1600-6143.2009.02560.x.
19.
LevesqueEHotiEKhalfallahM. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation. Liver Transpl. 2011;17(10):1159–1166. doi:10.1002/lt.22372.
20.
VenkateswaranRVTownendJNWilsonICMascaroJGBonserRSSteedsRP. Echocardiography in the potential heart donor. Transplantation. 2010;89(7):894–901. doi:10.1097/TP.0b013e3181cfe8e9.
21.
FengSGoodrichNPBragg-GreshamJL. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–790.
22.
WilsonDJFisherADasK. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation. 2003;75(10):1683–1687.
23.
AndreaniPHotiEde la SernaS. Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance. HPB (Oxford). 2010;12(7):439–446. doi:10.1111/j.1477-2574.2010.00194.x.
24.
McKeownDWBonserRSKellumJA. Management of the heartbeating brain-dead organ donor. Br J Anaesth. 2012;108(suppl 1):i96–i107. doi:10.1093/bja/aer351.
25.
HuntSABaldwinJBaumgartnerW. Cardiovascular management of a potential heart donor: a statement from the Transplantation Committee of the American College of Cardiology. Crit Care Med. 1996;24(9):1599–1601.
26.
NguyenHBRiversEPKnoblichBP. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637–1642.
27.
DeschênesMBelleSHKromRAZettermanRKLakeJR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation. 1998;66(3):302–310.
28.
HoofnagleJHLombarderoMZettermanRK. Donor age and outcome of liver transplantation. Hepatology. 1996;24(1):89–96.
29.
CuendeNMirandaBCanonJFGarridoGMatesanzR. Donor characteristics associated with liver graft survival. Transplantation. 2005;79(10):1445–1452.
30.
FigueiraERRMartinoRBGalvaoFHMachadoMACBacchellaTMachadoMCC. A modified score for evaluation of liver graft. In: 11th Annual International Congress Scientific Program [abstract 239]. Liver Transpl. 2005;11(7):C–60.
31.
BacchellaTGalvãoFHJesus de AlmeidaJLFigueiraERde MoraesACésar MachadoMC. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J. 2008;126(3):161–165.
32.
Fischer-FröhlichCLLauchartW. Expanded criteria liver donors (ECD): effect of cumulative risks. Ann Transplant. 2006;11(3):40–42.
33.
RamosHCLopezR. Critical care management of the brain dead organ donor. Curr Opin Organ Transplant. 2002;7(1):70–75.
34.
TotsukaEDodsonFUrakamiA. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999;5(5):421–428.
35.
MangusRSFridellJAViannaRM. Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation. 2010;90(4):438–443.
36.
PokornyHLangerFHerknerHSchernbergerRPlochlWSolimanT. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant. 2005;19(4):532–536.
CameronAMGhobrialRMYersizH. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243(6):748–753.
